Abstract
Alzheimer's disease (AD) presents a complex clinical challenge, necessitating exploration of innovative therapeutic approaches. This paper investigates the integration of a medicinal Cannabis MCT oil protocol, featuring specific THC and CBD ratios, within the care plans of three individuals diagnosed with AD. Drawing upon existing literature and detailed case studies, we evaluate the protocol's impact on symptom progression, quality of life, and caregiver burden. Our analysis suggests promising therapeutic benefits of medicinal Cannabis in mitigating symptoms associated with AD, underscoring the importance of further research in this evolving field. Keywords: alzheimer's disease, medicinal cannabis, THC, CBD, symptom management, caregiver burden, neuroprotection, anti-inflammatory properties
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
